Ambu A/s Class B · OMXCOP:AMBU_B
Ambu A/s Class B — Q1 2007/08 Earnings Presentation
19 slides from Ambu A/s Class B's earnings presentation, Jan 29, 2008
Slide 1: Q1 2007/08 presentation, 29 January 2008
Q1 2007/08 presentation, 29 January 2008 By K. E. Birk, CEO, Anders Arvai, CFO, and Henrik Wendler, COO
Slide 2: Agenda
Agenda Developments in Q1 Outlook for 2007/08 Focus areas in the coming period October 28, 2026 2
Slide 3: Highlights – Q1 2007/08
Highlights – Q1 2007/08 Revenue of DKK 187m – up 14% (19% in local currencies) Sales to the USA up 44% EBIT of DKK 16m against DKK 9m in Q1 2006/07 EBIT margin of 8.8% against 5.7% in Q1 2006/07 Profit before tax of DKK 13m against DKK 6m in Q1 2006/07 Free cash flow of DKK 16m against D
Slide 4: Revenue
Revenue Revenue of DKK 187m against DKK 164m last year The revenue was affected by special conditions in the USA in Q4 2006/07 – trading with most customers resumed Negative effect of exchange rates of approx. DKK 8m in Q1 New products contribute to growth October 28, 2026 4
Slide 5: Revenue by business area
Revenue by business area Growth Growth in local Q1 Q1 in DKK Currencies DKKm 2007/08 2006/07 % % Respiratory Care 75.0 59.6 26 32 Cardiology 64.1 59.4 8 11 Neurology 17.6 15.3 15 20 Training 17.5 17.0 3 4 Immobilization and other products 13.2 12.4 6 16 Total 187.4 163.7 14 19 Respiratory Care Cardi
Slide 6: Revenue by geographical region
Revenue by geographical region Growth Growth in local Q1 Q1 in DKK currencies DKKm 2007/08 2006/07 % % USA 52.2 40.9 28 44 Europe 122.9 112.6 9 10 Other 12.3 10.2 21 21 Total 187.4 163.7 14 19 Europe USA Growth exceeds market growth Sales up 44% Most customers have started trading with Ambu ag
Slide 7: Operating profit (EBIT)
Operating profit (EBIT) Increase in EBIT of 76% in Q1 2007/08 to DKK 16m against DKK 9m last year The improvement is primarily attributable to higher revenue Developments in exchange rates only had a limited effect on EBIT EBIT margin of 8.8% against 5.7% in Q1 2006/07 October 28, 2026 7
Slide 8: Cash flow
Cash flow Cash flows from operating activities of DKK 20m against DKK 10m in Q1 2006/07 Positive free cash flow of DKK 16m against a negative free cash flow of DKK 2m in Q1 2006/07 The improvement is primarily attributable to improved earnings and lower investments October 28, 2026 8
Slide 9: Situation in the USA
Situation in the USA Decision not to go ahead with specially discounted sales towards the end of 2006/07 Subsequent active targeting of customers The sales force primarily focuses on customers with considerable potential Focused sales efforts are continued October 28, 2026 9
Slide 10: Reorganisation of the development area
Reorganisation of the development area N ew P la tfo rm I n n ov a tion N ew Pro d u ct I n n ova tion L o cal R & D N e w p ro d u cts N ew fa m ily m em b e r s D en m ark a n d A s ia w ith in ex is tin g an d n ew g en eratio n s I m p ro v em en ts an d v arian ts b u s in es s areas o f ex is
Slide 11: New products
New products No new products launched in Q1 2007/08 Focus on a number of new development activities In the rest of 2007/08, 2–3 improved products or new variants will be launched within all 5 business areas The products launched in 2006/07 have all been positively received by the market, and
Slide 12: Reorganisation of the marketing area
Reorganisation of the marketing area P o rtfo lio Ma n ag em ent Ma rket S up p o rt S ea rch Portfolio managers within each individual business area. Improve knowledge of the market, optimise product portfolio, launch products and ensure product performance. Market support – support of subsidia
Slide 13: Patent case concerning laryngeal mask – status
Patent case concerning laryngeal mask – status Autumn 2005 LMA institutes legal proceedings against Ambu Germany claiming infringement of a German patent concerning the reinforcement of the tip of the laryngeal mask August 2006 Decision announced. Ambu is infringing patent August 2006 Launch of new
Slide 14: Agenda
Agenda Developments in Q1 Outlook for 2007/08 Focus areas in the coming period October 28, 2026 14
Slide 15: The outlook for 2007/08 is unchanged
The outlook for 2007/08 is unchanged Growth in revenue of approx. 8% measured in local currencies, corresponding to approx. DKK 750m (USD: 500) EBIT margin of 11.5-12% Profit before tax of 10.5-11% of revenue, or approx. DKK 80m Free cash flow of approx. DKK 45m (with investments amounting t
Slide 16: Agenda
Agenda Developments in Q1 Outlook for 2007/08 Focus areas in the coming period October 28, 2026 16
Slide 17: Focus areas
Focus areas Efficient implementation of changes within development as well as sales and marketing Launch of new and improved products Ensure growth in the USA Continued streamlining of production Focus on reducing unit costs and other costs through improved purchasing of raw materials and
Slide 18: Questions
Questions
Slide 19: For further information, please visit www.ambu.com
For further information, please visit www.ambu.com October 28, 2026 19